Italian Observational, Multicenter Study in HIV1 -Positive, Virosuppressed Patients Currently in Treatment With Ritonavir-boosted Protease Inhibitors (PI/r) Starting Cobicistat-boosted Darunavir (DRV/c - Rezolsta): the STart Of REzolsta (ST.O.RE.) Study

Trial Profile

Italian Observational, Multicenter Study in HIV1 -Positive, Virosuppressed Patients Currently in Treatment With Ritonavir-boosted Protease Inhibitors (PI/r) Starting Cobicistat-boosted Darunavir (DRV/c - Rezolsta): the STart Of REzolsta (ST.O.RE.) Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Cobicistat/darunavir (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms STORE
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 27 Oct 2017 Results of pharmacokinetic Ctrough analysis (n=44), presented at the 16th European AIDS Conference.
    • 27 Oct 2017 Results assessing patient reported outcomes presented at the 16th European AIDS Conference
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top